Stephens analyst Chris Cooley reported to investors that he has learned via industry sources that Larry Laber, the former EVP of Sales, North America, at Cutera has departed along with several sales personnel. While he has not yet spoken to the company to confirm the departures, he acknowledges the perception of heightened risk in the short run stemming from a sales leadership transition, Cooley stated. Despite the sales turnover, he keeps an Overweight rating and $45 price target on Cutera shares as he still sees the potential for accelerating organic revenue growth, Cooley added.

Latest data shows the largest indicative borrow rate increases among liquid option names include: Luminar Technologies (LAZR) 13.08% +3.40, Lithium Americas (LAC) 39.35% +2.00, Rumble (RUM) 33.08% +1.07, Cutera (CUTR) 65.23% +0.93, Gorilla Technology Group Inc (GRRR) 49.06% +0.53, Aquestive Therapeutics (AQST) 0.99% +0.44, Medical Properties Trust (MPW) 16.94% +0.20, Nikola (NKLA) 22.04% +0.17, SunPower (SPWR) 3.29% +0.16, and GameStop (GME) 1.74% +0.16.